- Home
- NMRA vs DXYZ Comparison
NMRA vs DXYZ Comparison
Compare NMRA & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- DXYZ
- Stock Information
- Founded
- NMRA 2019
- DXYZ N/A
- Country
- NMRA United States
- DXYZ
- Employees
- NMRA N/A
- DXYZ N/A
- Industry
- NMRA
- DXYZ
- Sector
- NMRA
- DXYZ
- Exchange
- NMRA Nasdaq
- DXYZ Nasdaq
- Market Cap
- NMRA 291.5M
- DXYZ 313.1M
- IPO Year
- NMRA 2023
- DXYZ 2024
- Fundamental
- Price
- NMRA $2.50
- DXYZ $24.39
- Analyst Decision
- NMRA Buy
- DXYZ
- Analyst Count
- NMRA 8
- DXYZ 0
- Target Price
- NMRA $7.43
- DXYZ N/A
- AVG Volume (30 Days)
- NMRA 2.3M
- DXYZ N/A
- Earning Date
- NMRA 11-06-2025
- DXYZ N/A
- Dividend Yield
- NMRA N/A
- DXYZ N/A
- EPS Growth
- NMRA N/A
- DXYZ N/A
- EPS
- NMRA N/A
- DXYZ N/A
- Revenue
- NMRA N/A
- DXYZ N/A
- Revenue This Year
- NMRA N/A
- DXYZ N/A
- Revenue Next Year
- NMRA N/A
- DXYZ N/A
- P/E Ratio
- NMRA N/A
- DXYZ N/A
- Revenue Growth
- NMRA N/A
- DXYZ N/A
- 52 Week Low
- NMRA $0.61
- DXYZ N/A
- 52 Week High
- NMRA $14.09
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- NMRA 68.71
- DXYZ 45.26
- Support Level
- NMRA $1.68
- DXYZ $23.00
- Resistance Level
- NMRA $2.72
- DXYZ $26.24
- Average True Range (ATR)
- NMRA 0.20
- DXYZ 1.24
- MACD
- NMRA 0.08
- DXYZ -0.01
- Stochastic Oscillator
- NMRA 81.89
- DXYZ 34.68
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.